Quigley Company, Inc. Asbestos Personal Injury Trust

The Quigley Company, Inc. Asbestos Personal Injury (PI) Trust was established in 2013 following approval of the company's Chapter 11 Reorganization Plan. Initially funded with $569 million, partly contributed by Pfizer, the Trust provides compensation to individuals harmed by exposure to asbestos in Quigley's refractory products, including sealants and cement.

History

Founded in 1916, Quigley Company began as a small refractory manufacturing business. By the 1930s, many of its products incorporated asbestos, significantly increasing health risks for workers and consumers. Although the company discontinued the use of asbestos before the 1970s, litigation related to asbestos exposure began in 1979.

Facing mounting lawsuits, Quigley filed for bankruptcy in 2004. As a subsidiary of Pfizer, efforts to resolve claims and restructure operations continued for several years. After internal disputes, the Reorganization Plan was finally approved in 2013, establishing the Quigley Asbestos PI Trust.

The Trust was created to process, liquidate, and pay valid asbestos personal injury claims under its Trust Distribution Procedures.

Why Choose Us for Your Asbestos Exposure Claim?

Free No-Obligation Review

We provide free no-obligation asbestos exposure case review

Contingency Representation

We work on a contingency basis, meaning there are no fees unless we collect for you

Expertise In Asbestos & Mesothelioma Lawsuits

We have experience winning claims against huge multi-national corporations

Eligibility and Claim Process

Expedited Review

This process applies to claims that meet the presumptive medical and exposure criteria for Disease Levels I - IV, VI, and VII.

Individual Review

This process is available for claims that do not meet presumptive criteria but still fall within the same disease levels.

FIFO Processing

All claims are reviewed and processed on a first - come, first - served basis.

Claim Submission Requirements

Diagnosis Evidence: Documentation proving diagnosis of an asbestos-related disease.

Quigley Exposure Evidence: Proof of exposure to Quigley products containing asbestos.

Medical Causation: Medical records establishing asbestos exposure as a contributing factor.

Compensation and Payment Structure

Disease Levels and Scheduled Values

Disease Level	Scheduled Value
Mesothelioma (Level VII)	$200,000
Lung Cancer I (Level VI)	$35,000
Lung Cancer II (Level V)	None - subject to individual review
Other Cancer (Level IV)	$15,000
Severe Asbestosis (Level III)	$35,000
Asbestosis/Pleural Disease (Level II)	$5,000
Asbestosis/Pleural Disease (Level I)	$2,000

Disease Level

Scheduled Value

Mesothelioma (Level VII)

$200,000

Lung Cancer I (Level VI)

$35,000

Lung Cancer II (Level V)

None - subject to individual review

Other Cancer (Level IV)

$15,000

Severe Asbestosis (Level III)

$35,000

Asbestosis/Pleural Disease (Level II)

$5,000

Asbestosis/Pleural Disease (Level I)

$2,000

The Trust offers settlement compensation for victims of asbestos exposure caused by Quigley Company's products. More information is available at https://www.quigleytrust.com/.